Search Count: 33
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-05-22 Classification: CYTOKINE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2024-05-22 Classification: CYTOKINE Ligands: A1H4A |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.16 Å Release Date: 2024-03-06 Classification: CYTOKINE Ligands: SO4 |
 |
Organism: Hiv-1 06tg.ht008
Method: X-RAY DIFFRACTION Resolution:3.07 Å Release Date: 2023-01-25 Classification: VIRUS Ligands: I6Q, NAG, IMD |
 |
Organism: Hiv-1 06tg.ht008
Method: X-RAY DIFFRACTION Resolution:2.77 Å Release Date: 2023-01-25 Classification: VIRUS Ligands: NAG, I6M, IMD |
 |
Organism: Rattus norvegicus, Gallus gallus, Bos taurus
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2017-09-20 Classification: CELL CYCLE Ligands: GTP, MG, CA, GDP, 7AO, MES, ACP |
 |
Discovery Of Cdz173 (Leniolisib), Representing A Structurally Novel Class Of Pi3K Delta-Selective Inhibitors
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.90 Å Release Date: 2017-09-20 Classification: TRANSFERASE Ligands: 9NQ |
 |
Organism: Rattus norvegicus, Gallus gallus, Bos taurus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2017-03-01 Classification: CELL CYCLE Ligands: GTP, MG, CA, GDP, MES, 7AK, ACP |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.02 Å Release Date: 2016-09-07 Classification: Transferase/Protein Transport/Inhibitor Ligands: 6CY |
 |
Discovery And Pharmacological Characterization Of Novel Quinazoline-Based Pi3K Delta-Selective Inhibitors
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.85 Å Release Date: 2016-08-10 Classification: TRANSFERASE Ligands: 6CY |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2016-03-30 Classification: VIRAL PROTEIN Ligands: 5VE |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2016-03-30 Classification: VIRAL PROTEIN Ligands: NAG, 5VG |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2016-03-30 Classification: VIRAL PROTEIN Ligands: FMT, NAG, 5VF |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2016-03-30 Classification: VIRAL PROTEIN Ligands: NAG, 5VH |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2015-03-18 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: FMT, GOL, 3YV |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2015-03-18 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: GOL, 3YX |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2015-03-18 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: GOL, 3YT |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2014-04-23 Classification: transferase/transferase inhibitor Ligands: 2X6 |
 |
Crystal Structure Of Clade C1086 Hiv-1 Gp120 Core In Complex With Dmj-Ii-121
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2013-05-29 Classification: VIRAL PROTEIN/INHIBITOR Ligands: 1C1, NAG, FMT |
 |
Crystal Structure Of Clade A/E 93Th057 Hiv-1 Gp120 H375S Core In Complex With Dmj-Ii-121
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2013-05-29 Classification: VIRAL PROTEIN/INHIBITOR Ligands: 1C1, EPE, NAG |